Literature DB >> 17132260

Caffeine content of decaffeinated coffee.

Rachel R McCusker1, Brian Fuehrlein, Bruce A Goldberger, Mark S Gold, Edward J Cone.   

Abstract

Caffeine is the most widely consumed drug in the world with coffee representing a major source of intake. Despite widespread availability, various medical conditions necessitate caffeine-restricted diets. Patients on certain prescription medications are advised to discontinue caffeine intake. Such admonition has implications for certain psychiatric patients because of pharmacokinetic interactions between caffeine and certain anti-anxiety drugs. In an effort to abstain from caffeine, patients may substitute decaffeinated for caffeinated coffee. However, decaffeinated beverages are known to contain caffeine in varying amounts. The present study determined the caffeine content in a variety of decaffeinated coffee drinks. In phase 1 of the study, 10 decaffeinated samples were collected from different coffee establishments. In phase 2 of the study, Starbucks espresso decaffeinated (N=6) and Starbucks brewed decaffeinated coffee (N=6) samples were collected from the same outlet to evaluate variability of caffeine content of the same drink. The 10 decaffeinated coffee samples from different outlets contained caffeine in the range of 0-13.9 mg/16-oz serving. The caffeine content for the Starbucks espresso and the Starbucks brewed samples collected from the same outlet were 3.0-15.8 mg/shot and 12.0-13.4 mg/16-oz serving, respectively. Patients vulnerable to caffeine effects should be advised that caffeine may be present in coffees purported to be decaffeinated. Further research is warranted on the potential deleterious effects of consumption of "decaffeinated" coffee that contains caffeine on caffeine-restricted patients. Additionally, further exploration is merited for the possible physical dependence potential of low doses of caffeine such as those concentrations found in decaffeinated coffee.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17132260     DOI: 10.1093/jat/30.8.611

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  15 in total

1.  Patient-centered imaging.

Authors:  E Gordon Depuey; John J Mahmarian; Todd D Miller; Andrew J Einstein; Christopher L Hansen; Thomas A Holly; Edward J Miller; Donna M Polk; L Samuel Wann
Journal:  J Nucl Cardiol       Date:  2012-04       Impact factor: 5.952

2.  Simultaneous Identification of Neutral and Anionic Species in Complex Mixtures without Separation.

Authors:  Yanchuan Zhao; Lily Chen; Timothy M Swager
Journal:  Angew Chem Int Ed Engl       Date:  2015-11-02       Impact factor: 15.336

Review 3.  Blood pressure in relation to coffee and caffeine consumption.

Authors:  Idris Guessous; Chin B Eap; Murielle Bochud
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

4.  Effect of caffeine on SPECT myocardial perfusion imaging during regadenoson pharmacologic stress: rationale and design of a prospective, randomized, multicenter study.

Authors:  Furqan H Tejani; Randall C Thompson; Ami E Iskandrian; Bruce E McNutt; Billy Franks
Journal:  J Nucl Cardiol       Date:  2010-11-17       Impact factor: 5.952

Review 5.  Caffeine in Kidney Stone Disease: Risk or Benefit?

Authors:  Paleerath Peerapen; Visith Thongboonkerd
Journal:  Adv Nutr       Date:  2018-07-01       Impact factor: 8.701

6.  The perils of ignoring history: Big Tobacco played dirty and millions died. How similar is Big Food?

Authors:  Kelly D Brownell; Kenneth E Warner
Journal:  Milbank Q       Date:  2009-03       Impact factor: 4.911

7.  Intermittent Nonhabitual Coffee Consumption and Risk of Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Jennifer Xu; Wenjun Fan; Matthew J Budoff; Susan R Heckbert; Ezra A Amsterdam; Alvaro Alonso; Nathan D Wong
Journal:  J Atr Fibrillation       Date:  2019-06-30

8.  Decaffeinated coffee and glucose metabolism in young men.

Authors:  James A Greenberg; David R Owen; Allan Geliebter
Journal:  Diabetes Care       Date:  2009-11-16       Impact factor: 19.112

9.  A randomised placebo-controlled trial to differentiate the acute cognitive and mood effects of chlorogenic acid from decaffeinated coffee.

Authors:  David A Camfield; Beata Y Silber; Andrew B Scholey; Karen Nolidin; Antionette Goh; Con Stough
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

10.  Systematic evaluation of "compliance" to prescribed treatment medications and "abstinence" from psychoactive drug abuse in chemical dependence programs: data from the comprehensive analysis of reported drugs.

Authors:  Kenneth Blum; David Han; John Femino; David E Smith; Scott Saunders; Thomas Simpatico; Stephen J Schoenthaler; Marlene Oscar-Berman; Mark S Gold
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.